EVT

EVT closed at $15.75 on November 6, 2.5% below its $16.15 52-week high and 40.4% above its $11.22 52-week low. On the two-year chart the shares peaked at a $17.75 close in August 2025, fell −14.7% in a single session on Aug 25, 2025 and drifted down to a May 2026 low before recovering through August–November 2026. Short-term structure is orderly: SMA5 > SMA20 > SMA60 re-formed on Oct 13, MACD has been above its signal since Sep 29, ADX reads 33.7 and Mansfield RS versus the S&P/ASX 200 is +15.9% and rising. The counterweights are an OBV bearish divergence flagged between Oct 9 and Nov 5, RSI at 67.4 near overbought, and a light-volume final session (0.579×) one day after a new 90-day closing high.

Snapshot as of November 6, 2026

① Price & Moving Averages

The two-year frame starts near $11.20 in late 2024 and climbs to a $17.75 close on Aug 18, 2025. On Aug 25, 2025 the shares fell −14.7% in one session on about 3.5× average volume — the bar that anchors the two-year aVWAP ($13.38). A rebound to $14.92 in November 2025 faded, and price drifted lower through the first half of 2026 to the $11.22 52-week low in May. The August 2026 results period then lifted it: Aug 24 closed +8.9% on 2.9× volume, touching the $16.15 intraday high that is still the 52-week high, and the opening gap that day has since been filled — the data shows no unfilled gaps.

On the 90-day frame, price eased from $15.43 (Aug 25) to $13.23 (Sep 11); the Sep 9 −3.98% session coincided with the ex-dividend date for a $0.23 dividend in the price data. Sep 18 traded about 9.2× average volume on a −0.4% close — the S&P/ASX September index rebalance day — and anchors the 90-day aVWAP ($14.03). From late September price climbed in steady steps to a $15.89 close on Nov 5, the highest close of the past year, and eased to $15.75 on Nov 6.

Condition timing: the close moved back above SMA60 on Sep 22 and above SMA20 on Sep 30. The SMA5 > SMA20 > SMA60 ordering — this bucket's defining condition — formed earlier on Jun 26 and Jul 30 (the latter run lasted to Sep 7), formed again on Sep 30 and broke on Oct 2, then re-formed on Oct 13 on a flat (0.00%) session with light volume; it has held since. The Fibonacci swing in the data runs from $14.98 (Oct 29) to $15.89 (Nov 5): the 23.6% retracement is $15.68, 38.2% is $15.54 and 61.8% is $15.33. The two-year Fibonacci set (an Aug 25 → Sep 11, 2026 down-swing) labels all its levels as resistance, but price has already closed above every one of them, so they now sit beneath the share price.

② Volume

The Sep 18 rebalance bar (about 4.55 million shares) dominates the 90-day panel. While it sat inside the 20-day average, from Sep 18 to mid-October, every other session read as very light — ratios of roughly 0.15–0.40× — so the low readings around the Sep 30 and Oct 13 formations understate actual participation. Once that bar left the window, the 20-day average settled at 176,862 shares.

In the last five sessions volume ran above average on four days: Nov 2 was flat (−0.26%) at 2.10×, Nov 3 +2.17% at 1.58×, Nov 4 −1.16% at 1.56× and Nov 5 +3.65% at 1.53×. The screened ASX universe's median volume ratio ran about 0.76–1.24× over this window, a normal range, so the Nov 2 activity stands out without a price move or an identified catalyst. The Nov 6 close came on 0.579× average volume — the push to the Nov 5 high was not followed by further participation.

③ MACD

The MACD line is 0.3702 against a signal of 0.3175, a histogram of +0.0527. The golden cross came on Sep 29 from below zero after the September pullback, and the line moved above zero in early October. Since then the histogram has stayed positive but modest, with a dip in late October and a small widening over the last few sessions. The line is still below its late-August peak; momentum is positive and steady rather than accelerating sharply. A cross back below the signal line would be the first sign of the advance losing force.

④ RSI

RSI(14) is 67.4 (67.3 on the two-year frame), above the 50 midline and just under 70. It reached the mid-30s at the September low, recovered through 50 in late September and has climbed in a gentle stair-step since, approaching the 70 line in the recent sessions. No RSI divergence is flagged on either frame. The reading describes firm momentum; at this level, further gains would push it into overbought territory, where pullbacks or sideways pauses become more common.

⑤ Mansfield Relative Strength

Mansfield RS vs the S&P/ASX 200 is +15.9%, well above zero (outperform) with a rising slope. A week earlier it was +13.57 and a month earlier +12.53, so it gained 2.36 points on the week and 3.40 on the month — both views in the positive-accelerating quadrant. On the 90-day panel RS crossed above zero in early August, dipped toward the zero line during the September pullback without breaking below it, and has climbed since. On the two-year panel this is the first sustained stretch above zero since the August 2025 drop. The selection's RS rank of 92 matches a stock that has been outperforming the index for three months rather than for a few sessions.

⑥ ATR & ADX

ATR(14) is $0.444, or 2.8% of price, which sets the 1×ATR reference at $15.31 and the 2×ATR technical invalidation level at $14.86, 5.6% below the close. ATR peaked after the August results-period sessions and has eased through September and October to a lower, steadier band. ADX is 33.7 (33.4 on the two-year frame), above the 25 line that marks a strong trend, and it has edged higher through October. ADX measures trend strength, not direction; alongside the rising moving averages it says the October–November advance has persistence. The SMA20 ($15.03) sits just above the $14.86 invalidation level.

⑦ OBV

OBV is tagged early distribution on both frames — below its MA20 with a flat slope — and a bearish OBV divergence is flagged on both: price made a higher high from $14.66 (Oct 9) to $15.89 (Nov 5) while OBV made a lower high, from −3,896,767 to −4,160,357 on the 90-day frame (−4,283,874 to −4,547,464 on the two-year frame). That is the classic non-confirmation of a new price high, and it is a reason for caution rather than a confirmed top.

Context matters here. OBV adds or subtracts a session's full volume by the sign of the close, so the Sep 18 rebalance bar — about 4.55 million shares on a −0.4% close — cut OBV by that amount in one step, the cliff visible on both panels. The negative OBV level and its position under MA20 owe much to that single session; since then OBV has drifted modestly higher and then flattened while price climbed. The OBV-to-MA20 gap is −5.42% on the two-year frame and −5.93% on the 90-day frame; these percentages measure distance from the moving average, not divergence.

Bull Case vs Bear Case

Scenarios

Key Levels & Volatility References

What to Watch

• The OBV divergence. A new price high with OBV also making a new high would cancel the non-confirmation; a pullback on rising volume would give it weight.
• The $15.89–$16.15 zone. A close above the Nov 5 high on above-average volume, then a test of the $16.15 August high, would extend the structure; repeated failures there would point to a range.
• RSI and the 70 line. At 67.4, a push above 70 would mark overbought conditions; a turn lower from here with price flat would show momentum cooling.
• SMA20 at $15.03. The October–November advance has stayed above it since Sep 30; a close below it would weaken the ordering.
• The $14.86 level. A daily close below the 2×ATR technical invalidation level would undo the current structure.

Conclusion

Past Analyses of This Stock same ticker · newest first

Other signals from this issue same publication date · 3 stocks

← All charts